Drug profile · INN
fitusiran sodium
QFITLIA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
fitusiran sodium (QFITLIA) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN fitusiran sodium
Brand QFITLIA
Route SUBCUTANEOUS
Formulation SOLUTION
Frequently asked questions
What is fitusiran sodium?
fitusiran sodium (QFITLIA) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for fitusiran sodium?
QFITLIA is a marketed brand name for fitusiran sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fitusiran sodium?
fitusiran sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.